InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+23.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Gangolli Julian S, Director. Insider active across 2 companies, notably Revance Therapeutics, Inc.. Aggregated, 7 reports have been published. History available since 5 May 2021. The latest transaction was filed on 4 February 2025 (U). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
30,106 shares@ US$3.65100.0% of flowCommon StockSEC:0000950170-25-015688:0
20,000 shares@ US$22.75100.0% of flowCommon StockSEC:0001532023-24-000008:0
15,000 shares0Common StockSEC:0001479290-24-000086:0
3,534 shares0Common StockSEC:0001479290-23-000064:0
6,059 shares0Common StockSEC:0001479290-22-000061:0
4,013 shares0Common StockSEC:0001479290-21-000108
4,013 shares0Common StockSEC:0001479290-21-000108:0
7 of 7 declarations
About Gangolli Julian S
Julian S. Gangolli serves as a Board Member at Revance Therapeutics, Inc. He contributes to the governance of the company by bringing his expertise in strategy and business development. His role is crucial in guiding strategic decisions and ensuring the growth of the organization.
